BCM
TMCI icon

Bridgeway Capital Management’s Treace Medical Concepts TMCI Stock Holding History

Bridgeway Capital Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$199K Hold
50,000
– – ﹤0.01% 1060
2026
Q1 		$67K Buy
+50,000
New +$99.7K ﹤0.01% 1169

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bridgeway Capital Management's TMCI Position: Q2 2026 in Review

Bridgeway Capital Management held its Treace Medical Concepts (TMCI) position steady in Q2 2026 at 50,000 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #1060.

Bridgeway Capital Management first reported a position in TMCI in Q1 2026 and has held it in 2 quarters since. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Bridgeway Capital Management held 50,000 shares of Treace Medical Concepts worth $199K as of Q2 2026.
  • Bridgeway Capital Management left its Treace Medical Concepts share count unchanged in Q2 2026.
  • Treace Medical Concepts made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #1060 holding.
  • Bridgeway Capital Management first reported a position in Treace Medical Concepts in Q1 2026 and has held it in 2 quarters since.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.